Yakira Capital Management’s Repare Therapeutics RPTX Stock Holding History

Yakira Capital Management’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-266,601	Closed	-$693K	–	226
2025 Q4	$693K	Buy	+266,601	New	+$537K	0.23%	86

Yakira Capital Management's RPTX Position: Q1 2026 in Review

Yakira Capital Management sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 266,601 shares — an estimated $693K sold.

Yakira Capital Management first reported a position in RPTX in Q4 2025 and held it in 1 quarter. The position peaked at $693K in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Yakira Capital Management reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Yakira Capital Management sold 266,601 Repare Therapeutics shares in Q1 2026, an estimated $693K.
Yakira Capital Management first reported a position in Repare Therapeutics in Q4 2025 and held it in 1 quarter.
Yakira Capital Management's Repare Therapeutics position peaked at $693K in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Yakira Capital Management's 13F filing for Q1 2026, filed 14 May 2026.